Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy

BACKGROUND: Galectin-1, a radioresistance marker, was found in our previous study to be a prognostic factor for cervical cancer. The aim of current study is to determine the prognostic significance of the galectin-1 expression level in patients with glioblastoma multiforme (GBM) undergoing adjuvant...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Shang-Yu, Yen, Shao-Lun, Huang, Chao-Cheng, Huang, Eng-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789739/
https://www.ncbi.nlm.nih.gov/pubmed/29378529
http://dx.doi.org/10.1186/s12885-018-4025-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789739/
https://www.ncbi.nlm.nih.gov/pubmed/29378529
http://dx.doi.org/10.1186/s12885-018-4025-2

Ejemplares similares